The global Bacterial and Viral Specimen Collection market reached a value of US$ 13.9 billion in 2021. Looking ahead, the market is expected to reach $ 37.2 billion by 2027, growing at a CAGR of 14.9% between 2022 and 2027.
Bacterial & Viral Specimen Collection is described as the collection of blood and other tissues from the body in order to run diagnoses to determine the illness the body is suffering from. The abundance of modern methods for conducting diagnosis, such anaerobic blood cultures that detect blood infections, diseases like Mycoplasma, Tb (Tuberculosis), and Pneumonia, etc., has made the outlook for the sector particularly alluring. To prevent bacterial contamination from the environment, the assemblage of the specimen is done with the utmost care in a clean environment. The equipment utilized should be of excellent quality to uphold the hygiene standards.
Worldwide manufacturing of viral specimen collection products has increased due to a rise in demand for diagnostic tests for COVID-19 from a number of vendors. The market for collecting bacterial and viral specimens is consequently being driven by this. According to research from April 2020, Puritan Medical Products has boosted the number of nasal swabs it produces each week for COVID-19 testing to more than 1.0 million, fueling the market's expansion. The market for bacterial and viral specimen collection is anticipated to be driven by key firms developing innovations that enable the error-free laboratory-quality specimen collection. Rapid diagnostic tests have become quite popular because they deliver precise data more quickly, enhance prescribing, and shorten hospital stays. These tests are widely regarded by medical professionals as a means of navigating a pandemic of infectious diseases that are extremely contagious, like Middle East respiratory syndrome coronavirus, Ebola, and others. This increases the use of products for collecting bacterial and viral specimens for rapid diagnostic tests.
14 September 2021: Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2--
Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test leverages the design principles of our current Xpert Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 45 minutes with less than a minute of hands-on time to prepare the sample.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
With a 43.8% revenue share in 2019, North America dominated the market for bacterial and viral specimen collecting. In this area, there is a high degree of knowledge about microbial illnesses, their diagnosis, and how to treat them effectively. This encourages widespread use of these products, increasing the region's revenue share. Government agencies' initiatives to encourage product development have a further impact on revenue growth. As of November 2019, the US HHS was funding the development of host-response testing technology through a USD 6.0 million contract with Inflammatix Inc. The business is working to create three diagnostic tests that can tell you quickly whether you have a viral or bacterial infection. This enables clinicians to decide on a patient's course of treatment earlier and with greater knowledge. The foundation of the corporations' goal to increase earlier detection is efforts like this.
The Asia Pacific market for bacterial and viral specimen collecting is predicted to grow at a rapid pace. This is a result of extensive coronavirus testing in Asian nations, particularly in India, the nation with the third-highest global effect. According to World meter statistics dated the 27th of July 2020, India had completed more than 16.0 million COVID-19 tests. One of the most common lower respiratory tract diseases in younger children in Japan is the Respiratory Syncytial Virus (RSV), which prompts the nation to respond swiftly to minimise outbreaks of RSV during epidemic RSV season.
The Bacterial and Viral Specimen Collection Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Bacterial and Viral Specimen Collection Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 14.9% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Puritan Medical Products, Nest Scientific, Quidel, Longhorn Vaccines and Diagnostics, Thermo Fisher Scientific, Pretium Packaging, Hardy Diagnostics, Trinity Biotech, VIRCELL, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., Spectrum Solutions L.L.C., Titan Biotech, DiaSorin, HI Media laboratories |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 133 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Bacterial and Viral Specimen Collection Market?
The Bacterial and Viral Specimen Collection Market is growing at a CAGR of 14.9% over the next 5 years.
Who are the key players in Bacterial and Viral Specimen Collection Market?
Puritan Medical Products, Nest Scientific, Quidel, Longhorn Vaccines and Diagnostics, Thermo Fisher Scientific, Pretium Packaging, Hardy Diagnostics, Trinity Biotech, VIRCELL, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., Spectrum Solutions L.L.C., Titan Biotech, DiaSorin, HI Media laboratories
What are the significant types of Bacterial and Viral Specimen Collection Market?
Bacterial Specimen Collection, Viral Specimen Collection
What are the major end-use applications of Bacterial and Viral Specimen Collection Market?
Hospitals and Clinics, Home Test, Research Laboratories
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.